Tang-Quan Karis R, Xi Yutao, Hochman-Mendez Camila, Xiang Qian, Lee Po-Feng, Sampaio Luiz C, Taylor Doris A
Regenerative Medicine Research, Texas Heart Institute, 6770 Bertner Ave, Houston, TX 77030 USA.
College of Veterinary Medicine & Biomedical Sciences, 400 Bizzell St., College Station, TX 77843 USA.
Cell Mol Bioeng. 2020 Jul 27;13(6):633-645. doi: 10.1007/s12195-020-00634-z. eCollection 2020 Dec.
Recellularization of organ decellularized extracellular matrix (dECM) offers a potential solution for organ shortage in allograft transplantation. Cell retention rates have ranged from 10 to 54% in varying approaches for reseeding cells in whole organ dECM scaffolds. We aimed to improve recellularization by using soluble gelatin as a cell carrier to deliver endothelial cells to the coronary vasculature and cardiomyocytes to the parenchyma in a whole decellularized rat heart.
Rat aortic endothelial cells (RAECs) were perfused over decellularized porcine aorta in low (1%) and high (5%) concentrations of gelatin to assess attachment to a vascular dECM model. After establishing cell viability and proliferation in 1% gelatin, we used 1% gelatin as a carrier to deliver RAECs and neonatal rat cardiomyocytes (NRCMs) to decellularized adult rat hearts. Immediate cell retention in the matrix was quantified, and recellularized hearts were evaluated for visible contractions up to 35 days after recellularization.
We demonstrated that gelatin increased RAEC attachment to decellularized porcine aorta; blocking integrin receptors reversed this effect. In the whole rat heart gelatin (1%) increased retention of both RAECs and NRCMs respectively, compared with the control group (no gelatin). Gelatin was associated with visible contractions of NRCMs within hearts (87% with gelatin vs. 13% control).
Gelatin was an effective cell carrier for increasing cell retention and contraction in dECM. The gelatin-cell-ECM interactions likely mediated by integrin.
器官脱细胞细胞外基质(dECM)的再细胞化可为同种异体移植中的器官短缺提供潜在解决方案。在将细胞重新接种到全器官dECM支架的不同方法中,细胞保留率在10%至54%之间。我们旨在通过使用可溶性明胶作为细胞载体,将内皮细胞输送到冠状动脉血管系统,并将心肌细胞输送到整个脱细胞大鼠心脏的实质中,以改善再细胞化。
将大鼠主动脉内皮细胞(RAECs)在低浓度(1%)和高浓度(5%)的明胶中灌注到脱细胞猪主动脉上,以评估其与血管dECM模型的附着情况。在确定细胞在1%明胶中的活力和增殖后,我们使用1%明胶作为载体,将RAECs和新生大鼠心肌细胞(NRCMs)输送到脱细胞成年大鼠心脏中。对基质中立即保留的细胞进行定量,并在再细胞化后长达35天内评估再细胞化心脏的可见收缩情况。
我们证明明胶增加了RAECs与脱细胞猪主动脉的附着;阻断整合素受体可逆转这种作用。在整个大鼠心脏中,与对照组(无明胶)相比,1%的明胶分别增加了RAECs和NRCMs的保留率。明胶与心脏内NRCMs的可见收缩有关(明胶组为87%,对照组为13%)。
明胶是一种有效的细胞载体,可增加dECM中的细胞保留和收缩。明胶-细胞-ECM相互作用可能由整合素介导。